Area of research
Transplantation · Infectious Diseases
Research interest
Research interests include Renal Transplantation Outcomes and Treatments, SARS-CoV-2 and COVID-19 Research, Artificial Intelligence in Healthcare and Education, and COVID-19 Clinical Research Studies.
Randomized trial of electronic health record implemented AI risk prediction in kidney transplant care
Human-centered AI in healthcare: empowering patients and support persons in clinical decision-making
Immunosuppression with cyclosporine versus tacrolimus shows distinctive nephrotoxicity profiles within renal compartments
Successful Desensitization with Imlifidase and Daratumumab in a Highly Immunized, Crossmatch Positive, Blood Group-Incompatible Living-Donor Re-Transplant Recipient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Donor-Derived Cell-Free DNA as a Companion Biomarker for AMR Treatment With Daratumumab: Case Series
Continuous glucose monitoring for the prediction of posttransplant diabetes mellitus and impaired glucose tolerance on day 90 after kidney transplantation—A prospective proof-of-concept study
Prospectively investigating the impact of AI on shared decision-making in post kidney transplant care (PRIMA-AI): protocol for a longitudinal qualitative study among patients, their support persons and treating physicians at a tertiary care centre
Investigating the Impact of AI on Shared Decision-Making in Post-Kidney Transplant Care (PRIMA-AI): Protocol for a Randomized Controlled Trial
Office or home versus 24-h blood pressure measurement in stable kidney transplant recipients
Donor-derived cell-free DNA as a marker of graft injury after solid organ transplantation
When performance is not enough—A multidisciplinary view on clinical decision support
Validation of risk scores for prediction of severe pneumonia in kidney transplant recipients hospitalized with community-acquired pneumonia
Donor-Derived Cell-Free DNA in Biopsy-Proven Antibody-Mediated Rejection Versus Recurrent IgA Nephropathy After Kidney Transplantation
Predictors of graft failure after first detection of <i>de novo</i> donor-specific HLA antibodies in kidney transplant recipients
Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients
Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
Donor-derived cell-free DNA as a diagnostic tool in transplantation
“Nothing works without the doctor:” Physicians’ perception of clinical decision-making and artificial intelligence
The natural history of de novo donor-specific HLA antibodies after kidney transplantation
A single centre in-depth analysis of death with a functioning kidney graft and reasons for overall graft failure
Evaluation of a clinical decision support system for detection of patients at risk after kidney transplantation
Donor-Derived Cell-free DNA for Personalized Immunosuppression in Renal Transplantation
Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipients
Poor Outcomes in Patients With Transplant Glomerulopathy Independent of Banff Categorization or Therapeutic Interventions
Initial Experience With SARS-CoV-2-Neutralizing Monoclonal Antibodies in Kidney or Combined Kidney-Pancreas Transplant Recipients
Absolute or Relative Quantification of Donor-derived Cell-free DNA in Kidney Transplant Recipients: Case Series
First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine – case report
Undoubtedly, kidney transplant recipients have a higher mortality due to COVID‐19 disease compared to the general population